Fonar Corp (FONR) Signs Definitive Agreement for Take-Private Sale, Shares Surge 24.5%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 30 2025
0mins
Should l Buy FONR?
Source: Benzinga
- Take-Private Agreement Signed: Fonar Corp announced the signing of a definitive agreement for a take-private sale, resulting in a 24.5% surge in pre-market shares to $18.25, indicating strong market confidence that could provide financial backing for future growth.
- Strong Market Reaction: The stock's robust performance in pre-market trading reflects optimistic investor sentiment regarding the privatization deal, potentially attracting more investor interest and enhancing the company's overall market capitalization.
- Significant Industry Impact: Fonar's privatization move may trigger similar actions among other medical device companies, prompting more firms in the sector to consider privatization to enhance operational efficiency and shareholder value.
- Future Strategic Direction: By going private, Fonar is expected to concentrate resources on its core business and optimize its operational model, thereby strengthening its market position and profitability in a highly competitive healthcare market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FONR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FONR
About FONR
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Legal Investigation Initiated: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc. (NASDAQ: RAPT) regarding its sale to GSK plc for $58.00 per share, potentially violating fiduciary duties to shareholders and impacting shareholder rights.
- Shareholder Rights Protection: The transaction between Penumbra, Inc. (NYSE: PEN) and Boston Scientific Corporation involves $374.00 in cash or 3.8721 shares of Boston Scientific common stock per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
- Cash and Stock Transaction: Calavo Growers, Inc. (NASDAQ: CVGW) is selling to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission stock per share, prompting Halper Sadeh LLC to assess the potential impact of this transaction on shareholders.
- Management Transaction Review: FONAR Corporation (NASDAQ: FONR) is involved in a transaction with its CEO and certain executives for $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, with Halper Sadeh LLC possibly advocating for enhanced shareholder rights.
See More
Investigation Alerts for Multiple Company Mergers
- RAPT Acquisition Investigation: RAPT Therapeutics is set to be acquired by GlaxoSmithKline for $58 per share, totaling an estimated equity value of $2.2 billion, with investigations focusing on whether the board failed to conduct a fair process, potentially impacting shareholder rights.
- Calavo Merger Details: Calavo Growers will be acquired by Mission Produce, with shareholders receiving $27 per share, including $14.85 in cash and 0.9790 shares of Mission, valuing the transaction at approximately $430 million, while investigations examine if the board breached fiduciary duties to shareholders.
- Penumbra Acquisition Status: Penumbra will be acquired by Boston Scientific in a deal valuing the company at $374 per share, reflecting an enterprise value of about $14.5 billion, with investigations looking into whether the board ensured a fair process, potentially affecting shareholder interests.
- FONAR Merger Investigation: FONAR Corporation is to be acquired by FONAR, LLC for $19 per share in an all-cash transaction, with investigations questioning whether the board failed to conduct a fair process, which could impact shareholder rights.
See More
Investigation Launched into FONAR Corporation's Board Actions
- Investigation Initiated: Levi & Korsinsky, LLP has officially launched an investigation into potential breaches of fiduciary duty by the board of FONAR Corporation (NASDAQ:FONR), focusing on a management-led take-private merger approved in December 2025.
- Merger Scrutiny: The investigation examines whether the management-led merger involved conflicts of interest that could adversely affect shareholder rights, potentially leading to significant implications for the company's governance structure.
- Legal Expertise: Levi & Korsinsky is a nationally recognized law firm specializing in securities litigation, having recovered hundreds of millions for investors, showcasing its expertise in handling such cases effectively.
- Shareholder Rights Protection: This investigation aims to safeguard the interests of FONAR shareholders, underscoring the importance of governance transparency and potentially prompting stricter regulatory measures in the future.
See More
Investor Rights Investigation: Potential Violations in Multiple Company Transactions
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Stellar Bancorp, Inc.'s sale involving 0.3803 shares of Prosperity common stock and $11.36 in cash per share, potentially indicating breaches of fiduciary duties to shareholders.
- Merger Scrutiny: The merger of Bakkt Holdings, Inc. with Distributed Technologies Research Ltd. is under review, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures for shareholders.
- Executive Transaction Investigation: The sale of FONAR Corporation to CEO Timothy Damadian and other executives, involving $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, raises concerns about potential conflicts of interest.
- Cash Acquisition Review: Clearwater Analytics Holdings, Inc.'s sale to Permira and Warburg Pincus for $24.55 per share in cash is being evaluated by Halper Sadeh LLC for potential violations of shareholder rights.
See More
Kaskela Law Investigates FONAR Buyout Proposal
- Buyout Price Investigation: Kaskela Law LLC is investigating the proposed acquisition of FONAR Corp. at $19.00 per share, suggesting that this price may materially undervalue the company and harm investor interests.
- Shareholder Rights Protection: The investigation aims to determine whether FONAR shareholders will receive adequate financial compensation and whether company executives breached their fiduciary duties or violated securities laws during the sale process.
- Post-Transaction Consequences: Once the transaction closes, FONAR shareholders will be cashed out, and the company's shares will cease to be publicly traded, impacting investors' liquidity and future investment options.
- Legal Consultation Call: Kaskela Law LLC encourages FONAR shareholders to contact their attorneys for more information, ensuring they understand their legal rights and options to protect their interests.
See More
Investigation of Investor Rights: FONAR and Others
- FONAR Transaction Investigation: Halper Sadeh LLC is investigating FONAR Corporation (NASDAQ:FONR) regarding a sale to CEO Timothy Damadian and other executives for $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, potentially indicating breaches of fiduciary duties to shareholders.
- Heritage Commerce Sale: Heritage Commerce Corp (NASDAQ:HTBK) is involved in a sale to CVB Financial Corp. for 0.6500 shares of CVB common stock for each Heritage share, with Halper Sadeh LLC assessing the implications for shareholder rights.
- DigitalBridge Sale Review: DigitalBridge Group, Inc. (NYSE:DBRG) is selling to SoftBank Group Corp. for $16.00 per share in cash, and Halper Sadeh LLC may seek increased consideration and additional disclosures for shareholders.
- Legal Consultation Services: Halper Sadeh LLC offers free legal consultations, encouraging shareholders to reach out to discuss their rights and options, highlighting their expertise in securities fraud and corporate misconduct cases.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Legal Investigation Initiated: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc. (NASDAQ: RAPT) regarding its sale to GSK plc for $58.00 per share, potentially violating fiduciary duties to shareholders and impacting shareholder rights.
- Shareholder Rights Protection: The transaction between Penumbra, Inc. (NYSE: PEN) and Boston Scientific Corporation involves $374.00 in cash or 3.8721 shares of Boston Scientific common stock per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
- Cash and Stock Transaction: Calavo Growers, Inc. (NASDAQ: CVGW) is selling to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission stock per share, prompting Halper Sadeh LLC to assess the potential impact of this transaction on shareholders.
- Management Transaction Review: FONAR Corporation (NASDAQ: FONR) is involved in a transaction with its CEO and certain executives for $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, with Halper Sadeh LLC possibly advocating for enhanced shareholder rights.
See More
Investigation Alerts for Multiple Company Mergers
- RAPT Acquisition Investigation: RAPT Therapeutics is set to be acquired by GlaxoSmithKline for $58 per share, totaling an estimated equity value of $2.2 billion, with investigations focusing on whether the board failed to conduct a fair process, potentially impacting shareholder rights.
- Calavo Merger Details: Calavo Growers will be acquired by Mission Produce, with shareholders receiving $27 per share, including $14.85 in cash and 0.9790 shares of Mission, valuing the transaction at approximately $430 million, while investigations examine if the board breached fiduciary duties to shareholders.
- Penumbra Acquisition Status: Penumbra will be acquired by Boston Scientific in a deal valuing the company at $374 per share, reflecting an enterprise value of about $14.5 billion, with investigations looking into whether the board ensured a fair process, potentially affecting shareholder interests.
- FONAR Merger Investigation: FONAR Corporation is to be acquired by FONAR, LLC for $19 per share in an all-cash transaction, with investigations questioning whether the board failed to conduct a fair process, which could impact shareholder rights.
See More
Investigation Launched into FONAR Corporation's Board Actions
- Investigation Initiated: Levi & Korsinsky, LLP has officially launched an investigation into potential breaches of fiduciary duty by the board of FONAR Corporation (NASDAQ:FONR), focusing on a management-led take-private merger approved in December 2025.
- Merger Scrutiny: The investigation examines whether the management-led merger involved conflicts of interest that could adversely affect shareholder rights, potentially leading to significant implications for the company's governance structure.
- Legal Expertise: Levi & Korsinsky is a nationally recognized law firm specializing in securities litigation, having recovered hundreds of millions for investors, showcasing its expertise in handling such cases effectively.
- Shareholder Rights Protection: This investigation aims to safeguard the interests of FONAR shareholders, underscoring the importance of governance transparency and potentially prompting stricter regulatory measures in the future.
See More
Investor Rights Investigation: Potential Violations in Multiple Company Transactions
- Shareholder Rights Investigation: Halper Sadeh LLC is investigating Stellar Bancorp, Inc.'s sale involving 0.3803 shares of Prosperity common stock and $11.36 in cash per share, potentially indicating breaches of fiduciary duties to shareholders.
- Merger Scrutiny: The merger of Bakkt Holdings, Inc. with Distributed Technologies Research Ltd. is under review, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures for shareholders.
- Executive Transaction Investigation: The sale of FONAR Corporation to CEO Timothy Damadian and other executives, involving $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, raises concerns about potential conflicts of interest.
- Cash Acquisition Review: Clearwater Analytics Holdings, Inc.'s sale to Permira and Warburg Pincus for $24.55 per share in cash is being evaluated by Halper Sadeh LLC for potential violations of shareholder rights.
See More
Kaskela Law Investigates FONAR Buyout Proposal
- Buyout Price Investigation: Kaskela Law LLC is investigating the proposed acquisition of FONAR Corp. at $19.00 per share, suggesting that this price may materially undervalue the company and harm investor interests.
- Shareholder Rights Protection: The investigation aims to determine whether FONAR shareholders will receive adequate financial compensation and whether company executives breached their fiduciary duties or violated securities laws during the sale process.
- Post-Transaction Consequences: Once the transaction closes, FONAR shareholders will be cashed out, and the company's shares will cease to be publicly traded, impacting investors' liquidity and future investment options.
- Legal Consultation Call: Kaskela Law LLC encourages FONAR shareholders to contact their attorneys for more information, ensuring they understand their legal rights and options to protect their interests.
See More
Investigation of Investor Rights: FONAR and Others
- FONAR Transaction Investigation: Halper Sadeh LLC is investigating FONAR Corporation (NASDAQ:FONR) regarding a sale to CEO Timothy Damadian and other executives for $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, potentially indicating breaches of fiduciary duties to shareholders.
- Heritage Commerce Sale: Heritage Commerce Corp (NASDAQ:HTBK) is involved in a sale to CVB Financial Corp. for 0.6500 shares of CVB common stock for each Heritage share, with Halper Sadeh LLC assessing the implications for shareholder rights.
- DigitalBridge Sale Review: DigitalBridge Group, Inc. (NYSE:DBRG) is selling to SoftBank Group Corp. for $16.00 per share in cash, and Halper Sadeh LLC may seek increased consideration and additional disclosures for shareholders.
- Legal Consultation Services: Halper Sadeh LLC offers free legal consultations, encouraging shareholders to reach out to discuss their rights and options, highlighting their expertise in securities fraud and corporate misconduct cases.
See More
